Study using novel approach for glioblastoma treatment shows promising results, extending survival

A new international study published in and presented as a late-breaking abstract at the American Association of Neurological Surgeons (AANS) annual conference, shows great promise for patients with glioblastoma. Drs. Farshad Nassiri and Gelareh Zadeh, neurosurgeons and scientists at the University Health Network (UHN) in Toronto, published the results of a Phase 1/2 clinical trial investigating the safety and effectiveness of a novel therapy which combines the injection of an oncolytic virus – a virus that targets and kills cancer cells – directly into the tumour, with intravenous immunotherapy.

Multimodal Sequencing Achieves High-Quality Results from Small Volumes of Frozen Tumor Specimens

Columbia researchers invent a multimodal sequencing technique that achieves high-quality results from small volumes of frozen tumor specimens–the ability to study cancer tissues archived in biobanks should increase the number and variety of tumor samples available for scientific analysis and advance the discovery of biomarkers and drug targets.